Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With <i>E coli</i> or <i>Klebsiella pneumoniae</i> Bloodstream Infection and Ceftriaxone Resistance

Patrick N. A. Harris(University of Technology Sydney), David L. Paterson(The University of Queensland), Amy Crowe(St Vincent's Hospital Melbourne), Nick Daneman(University of Toronto), Thamer H. Alenazi(King Saud bin Abdulaziz University for Health Sciences), Tom Boyles(Groote Schuur Hospital), Yin Mo(National University Hospital), Yaseen M. Arabi(King Saud bin Abdulaziz University for Health Sciences), Penelope Lorenc(The University of Queensland), Souha S. Kanj(American University of Beirut Medical Center), Paul R. Ingram(Fiona Stanley Hospital), Matteo Bassetti(University of Udine), David Chien Lye(National University of Singapore), Benjamin A. Rogers(Monash University), Genevieve Walls(Middlemore Hospital), Paul Anantharajah Tambyah(National University of Singapore), Marc Mendelson(University of Cape Town), Marco Falcone, David Looke(The University of Queensland), Jonathan R. Iredell(Westmead Hospital), Tau H. Lee(Tan Tock Seng Hospital), Hasan Bhally(North Shore Hospital), Elda Righi(Ospedale Santa Maria della Misericordia di Udine), Mesut Yılmaz(Istanbul Medipol University), Paul Griffin(The University of Queensland), Leah W. Roberts(The University of Queensland), Ahmed Zikri(King Fahad Specialist Hospital), Eugene Athan(Deakin University), Scott A. Beatson(The University of Queensland), Peter Baker(The University of Queensland), Anton Y. Peleg(Monash University), Tiffany Harris‐Brown(The University of Queensland), Mohammed Al Khamis(King Fahad Specialist Hospital), Spiros Miyakis(UNSW Sydney)
JAMA
September 11, 2018
Cited by 761


Related Papers